Prosecution Insights
Last updated: April 19, 2026

Transcode Therapeutics, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18270361 TEMPLATE DIRECTED IMMUNOMODULATION FOR CANCER THERAPY BROWE, DAVID 1617 Non-Final OA Jun 29, 2023
18215550 NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY CABRAL, ROBERT S 1614 Non-Final OA Jun 28, 2023

Managing Transcode Therapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month